Accounts Receivable Securitization Facility	3 Months Ended
Mar. 31, 2025
Accounts Receivable Securitization Facility [Abstract]
Accounts Receivable Securitization Facility	Accounts Receivable Securitization Facility In September 2022, the Company entered into a three-year revolving securitization facility agreement to transfer customer receivables of one of our U.S. subsidiaries (“Originator”) through our bankruptcy-remote subsidiary (“SPE”) to a third-party financial institution (“Purchaser”) on a recurring basis in exchange for cash equal to the gross receivables transferred. In November 2024, the agreement was amended to extend the term date from September 9, 2025 to November 18, 2027. The facility had a monthly drawing limit of $215 million at both March 31, 2025 and December 31, 2024. Transfers of our U.S. accounts receivable from the SPE to the Purchaser are accounted for as a sale of financial assets, and the accounts receivable are derecognized from the consolidated financial statements, as the SPE transfers effective control and risk associated with the transferred accounts receivable. Other than collection and administrative responsibilities, the Company and related subsidiaries have no continuing involvement in the transferred accounts receivable. The accounts receivable, once sold, are no longer available to satisfy creditors of the Company or the related subsidiaries in the event of bankruptcy. These sales are transacted at the face value of the relevant accounts receivable. The future outstanding balance of trade receivables that will be sold is expected to vary based on the level of activity and other factors. The receivables sold are fully guaranteed by the SPE that also pledges further accounts receivable as collateral under this agreement. The Company controls and therefore consolidates the SPE in its consolidated financial statements. The Company derecognized accounts receivable of $208.3 million and $235.8 million for the three months ended March 31, 2025 and 2024, respectively. The Company collected $208.3 million and $235.8 million of accounts receivable sold under this agreement during the three months ended March 31, 2025 and 2024, respectively. Unsold accounts receivable of $50.5 million and $95.5 million were pledged by the SPE as collateral to the Purchaser as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025 and December 31, 2024, recourse liability related to the receivables sold that has not been collected was immaterial. Fees incurred for the facility, including fees for administrative responsibilities, during the three months ended March 31, 2025 and 2024 were $3.1 million and $3.8 million, respectively, and have been reflected within "Non-operating income (expense) – net" in the condensed consolidated statements of operations and comprehensive income (loss). Cash activity related to the facility is reflected in "Net cash provided by operating activities" in the condensed consolidated statements of cash flows.

In September 2022, the Company entered into a three-year revolving securitization facility agreement to transfer customer receivables of one of our U.S. subsidiaries (“Originator”) through our bankruptcy-remote subsidiary (“SPE”) to a third-party financial institution (“Purchaser”) on a recurring basis in exchange for cash equal to the gross receivables transferred. In November 2024, the agreement was amended to extend the term date from September 9, 2025 to November 18, 2027. The facility had a monthly drawing limit of $215 million at both March 31, 2025 and December 31, 2024. Transfers of our U.S. accounts receivable from the SPE to the Purchaser are accounted for as a sale of financial assets, and the accounts receivable are derecognized from the consolidated financial statements, as the SPE transfers effective control and risk associated with the transferred accounts receivable. Other than collection and administrative responsibilities, the Company and related subsidiaries have no continuing involvement in the transferred accounts receivable. The accounts receivable, once sold, are no longer available to satisfy creditors of the Company or the related subsidiaries in the event of bankruptcy. These sales are transacted at the face value of the relevant accounts receivable. The future outstanding balance of trade receivables that will be sold is expected to vary based on the level of activity and other factors. The receivables sold are fully guaranteed by the SPE that also pledges further accounts receivable as collateral under this agreement. The Company controls and therefore consolidates the SPE in its consolidated financial statements.

The Company derecognized accounts receivable of $208.3 million and $235.8 million for the three months ended March 31, 2025 and 2024, respectively. The Company collected $208.3 million and $235.8 million of accounts receivable sold under this agreement during the three months ended March 31, 2025 and 2024, respectively. Unsold accounts receivable of $50.5 million and $95.5 million were pledged by the SPE as collateral to the Purchaser as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025 and December 31, 2024, recourse liability related to the receivables sold that has not been collected was immaterial.

Fees incurred for the facility, including fees for administrative responsibilities, during the three months ended March 31, 2025 and 2024 were $3.1 million and $3.8 million, respectively, and have been reflected within "Non-operating income (expense) – net" in the condensed consolidated statements of operations and comprehensive income (loss).